-
Medical journals
- Career
Use of the S-100 Protein as a Tumour Marker in Malignant Melanoma
Authors: E. Minariková 1; R. Pullmann 2; N. Karafová 2; J. Péč 1; Z. Frličková 1; Ľ. Lauko 3
Authors‘ workplace: Dermatovenerologická klinika JLF UK a Martinskej fakultnej nemocnice, prednosta prof. MUDr. J. Péč, CSc. 2Ústav klinickej biochémie JLF UK a Martinskej fakultnej nemocnice, prednosta prof. MUDr. RNDr. R. Pullmann, CSc. 3Ústav patologickej anatómie JLF UK 1
Published in: Čes-slov Derm, , 2003, No. 4, p. 156-158
Category:
Overview
The authors present results of determinations of S-100 protein in the serum by the immunoradiologicalmethodin the Sangtec S-100 IRMA test in 109 patients in four stages of malignant melanomain the years 2000-2002. In the series of patients there have been found the highest mean values of15.4
Key words:
S-100 protein - malignant melanoma - tumour marker
Labels
Dermatology & STDs Paediatric dermatology & STDs
Article was published inCzech-Slovak Dermatology
2003 Issue 4-
All articles in this issue
- Use of the S-100 Protein as a Tumour Marker in Malignant Melanoma
- Palmo-plantar Erythrodysesthesia caused by Liposome-encapsulated Doxorubicin
- Granular Parakeratosis
- Malignant Eccrine Poroma (Eccrine Porocarcinoma)
- Digitalized Dermatoscopy in Investigation of Pigmented Skin Lesions (PreliminaryClinical Experience)
- Fibrous Nodules in Lyme Borreliosis
- Czech-Slovak Dermatology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue- Granular Parakeratosis
- Palmo-plantar Erythrodysesthesia caused by Liposome-encapsulated Doxorubicin
- Malignant Eccrine Poroma (Eccrine Porocarcinoma)
- Fibrous Nodules in Lyme Borreliosis
Login#ADS_BOTTOM_SCRIPTS#Forgotten passwordEnter the email address that you registered with. We will send you instructions on how to set a new password.
- Career